Ashley Otto, Pharm.D., BCPS describes the pathophysiology of non-pulmonary clinical manifestations in cystic fibrosis (CF), reviews guideline recommendations and primary literature to manage non-pulmonary CF complications, and selects appropriate treatment options for patients with non-pulmonary CF complications. 

For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs @MayoPharmRes or the host, Garrett E. Schramm, Pharm.D., @garrett_schramm on Twitter!

You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.